Skip to main content
. Author manuscript; available in PMC: 2013 Nov 22.
Published in final edited form as: Cancer Res. 2012 Aug 8;72(19):10.1158/0008-5472.CAN-12-1248. doi: 10.1158/0008-5472.CAN-12-1248

Figure 6.

Figure 6

GLI1 expression inversely correlates with DFS and OS in primary human breast tumors. A, representative pictures of breast tumors (H&E), GLI1, and BMI1 (immunohistochemistry). B, comparison of DFS amongst breast cancer patients with ER-positive tumors expressing high versus low GLI1. C, comparison of DFS amongst breast cancer patients with node positive, ER-positive tumors expressing high versus low GLI1. D, comparison of overall survival amongst patients with breast cancer tumors expressing high versus low GLI1.